Back to MW MARSHALL WACE, LLP

RCKTRCKT
21 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ROCKET PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 4M shares of RCKT (ROCKET PHARMACEUTICALS INC), worth $13.8M as of 2026-Q2. The position was increased (+32.6% shares). RCKT represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$13.8M

Current Shares

4M

Total Value Change

+$8.7M

Total Shares Change

+3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4M
+32.6%
$13.8M0.0%$3.42
36
2026-Q1
Increased
3M
+114x
$10.9M0.0%$4.80
45
2025-Q4
New
26,347
-
$92,4780.0%$3.42
30
2025-Q2
Exited
0
-100.0%
$00.0%$2.53
0
2025-Q1
Decreased
438,617
-4.0%
$2.9M0.0%$7.59
0
2024-Q4
Increased
456,762
+4422.4%
$5.7M0.0%$12.03
44
2024-Q3
Decreased
10,100
-48.4%
$186,5470.0%$18.46
0
2024-Q2
New
19,583
-
$421,6220.0%$21.53
33
2023-Q1
Exited
0
-100.0%
$00.0%$16.29
0
2022-Q4
Decreased
13,500
-86.8%
$264,1950.0%$19.57
0
2022-Q3
Increased
101,856
+638.1%
$1.6M0.0%$14.04
41
2022-Q2
New
13,800
-
$190,0000.0%$13.03
31
2022-Q1
Exited
0
-100.0%
$00.0%$15.95
0
2021-Q4
New
95,569
-
$2.1M0.0%$22.93
36
2021-Q1
Exited
0
-100.0%
$00.0%$43.34
0
2020-Q4
New
35,390
-
$1.9M0.0%$56.05
36
2020-Q1
Exited
0
-100.0%
$00.0%$14.29
0
2019-Q4
Increased
3,877
+197.3%
$88,0000.0%$23.12
35
2019-Q3
Decreased
1,304
-99.0%
$15,0000.0%$11.71
0
2019-Q2
Decreased
131,748
-54.9%
$2M0.0%$15.00
0
2019-Q1
New
291,984
-
$5.1M0.0%$17.54
37

Other major holders of RCKT: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used